| C11orf30 |
Homo sapiens |
|
C11orf30 is differentially expressed in 70 experiments [83 up/84 dn]: 26 organism parts: bone marrow [0 up/2 dn], tonsil [1 up/1 dn], ...; 17 disease states: normal [3 up/3 dn], breast carcinoma [2 up/0 dn], ...; 18 cell types, 25 cell lines, 17 compound treatments and 19 other conditions. |
| C11orf30, EMSY, GL002, hCG_2018629 |
|
zgc:56039 (Danio rerio)
2210018M11Rik (Mus musculus)
CG15356 (Drosophila melanogaster)
2210018M11Rik (Rattus norvegicus)
(Compare orthologs)
|
|
|
| ENT |
|
|
| DNA repair, chromatin modification, nucleus, transcription, regulation of transcription |
|
|
|
Q17RM7
Q7Z589
|
|
|
|
ENSG00000158636
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MDA-MB-231
|
Cell line |
|
|
MK886
|
Compound treatment |
|
|
Breast carcinoma
|
Disease state |
|
|
Not applicable
|
Histology |
|
|
Stromal cell
|
Cell type |
|
|
Placebo
|
Compound treatment |
|
|
Endothelial cell
|
Cell type |
|
|
N/a
|
Test result |
|
|
Bone marrow
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Cerebellum
|
Organism part |
|
|
White blood cells
|
Organism part |
|
|
Macaca mulatta
|
Organism |
|
|
Homo sapiens
|
Organism |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
HPL1
|
Cell line |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Spermatid
|
Cell type |
|
|
Testis
|
Organism part |
|
|
MKN28
|
Cell line |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Spermatocyte
|
Cell type |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
BT-474
|
Cell line |
|
|
Caudate nucleus
|
Organism part |
|
|
Pan troglodytes
|
Organism |
|
|
Oligodendroglioma
|
Disease state |
|
|
BT474
|
Cell line |
|
|
Skeletal muscle
|
Organism part |
|
|
Cartilage
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
Seminiferous tubule
|
Organism part |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Epilepsy
|
Disease state |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
A549
|
Cell line |
|
|
Cancer13
|
Replicate |
|
|
Grade II
|
Tumor grading |
|
|
Actinomycin D
|
Compound treatment |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
Tumor
|
Organism part |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Ciliary ganglion
|
Organism part |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
HL-60
|
Cell line |
|
|
M1 macrophage
|
Cell type |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
HeLa
|
Cell line |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Interferon-gamma + lipopolysac...
|
Compound treatment |
|
|
Glutamine
|
Compound treatment |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
Cystic change
|
Histology |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Primary gastric tumor
|
Organism part |
|
|
Heregulin
|
Compound treatment |
|
|
SsMCF7
|
Cell line |
|
|
Lung
|
Organism part |
|
|
17/46
|
Genotype |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Rapamycin
|
Compound treatment |
|
|
Baseline uninfected
|
Disease state |
|
|
Secretory cell
|
Cell type |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
Metastatic
|
Disease staging |
|
|
CXCR5(hi)ICOS(hi) CD4 T cell
|
Target cell type |
|
|
Smooth muscle
|
Organism part |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
Blood
|
Organism part |
|
|
Capan-2
|
Cell line |
|
|
SKMEL5
|
Cell line |
|
|
Epithelial cell
|
Cell type |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Fibroblast
|
Cell type |
|
|
Filtered air
|
Compound treatment |
|
|
PT2
|
Disease staging |
|
|
Lymphoid tissue
|
Organism part |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Skin
|
Organism part |
|
|
Mannitol
|
Compound treatment |
|
|
MCF7
|
Cell line |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
Pt45P1
|
Cell line |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
T47D
|
Cell line |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
T cell
|
Cell type |
|
|
Anaplastic mixed oligo-astrocy...
|
Disease state |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
Breast cancer
|
Disease state |
|
|
Cervical cancer
|
Disease state |
|
|
Media only
|
Growth condition |
|
|
Pons
|
Organism part |
|
|
Primary
|
Disease staging |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
T84
|
Cell line |
|
|
Caco-2
|
Cell line |
|
|
CD34+
|
Cell type |
|
|
Kidney
|
Organism part |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
SNU1
|
Cell line |
|
|
Monocyte
|
Cell type |
|
|
Umbilical cord
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
Selenium
|
Compound treatment |
|
|
DMSO
|
Vehicle |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Idiopathic infertility
|
Clinical history |
|
|
Liver
|
Organism part |
|
|
SKBR3
|
Cell line |
|
|
MCF-7
|
Cell line |
|
|
Met5A
|
Cell line |
|
|
|
|
|
Processing time: 0.155 secs.